Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Stocks Open Lower on Weak China Data
Stocks opened Tuesday's session lower after data in China showed slow growth in services activity.
Big Business This Week: Walgreens CEO Out, Best Buy Outlook, Hiring Report and More
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Tesla Reveals Updated Model 3 With Higher Price Tag
Tesla has revealed its updated Model 3.
Ford Recalling 169,000 Vehicles to Replace Rear Cameras
Ford is recalling 169,000 vehicles to replace rearview cameras.
Robinhood to Buy Back Sam Bankman-Fried's Shares
Robinhood said it would buy back shares from disgraced former FTX head Sam Bankman-Fried.
Walgreens CEO Steps Down
Walgreens said its CEO Rosalind Brewer has stepped down and appointed an interim CEO while a search for a replacement is underway.
FTC Allows Amgen to Buy Horizon for $27.8 Billion
The Federal Trade Commission has given the green light to Amgen's purchase of Horizon Therapeutics.
Mortgage Rates Down This Week After Several Increases
Mortgage rates were down this week after being up for the past five weeks.
U.S. Adds 187,000 Jobs in August
U.S. job growth remained strong in August but showed signs of cooling.
